# Carvedilol Vascular Efficacy Trial

> **NCT01484327** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 415 (actual)

## Conditions studied

- Heart Failure
- Acute Myocardial Infarction

## Interventions

- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT01484327
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484327, "Carvedilol Vascular Efficacy Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01484327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*